Treatment of hypertensive crisis.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005292:Ferricyanides / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D006974:Hypertension, Malignant / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D010425:Pentolinium Tartrate / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D014294:Trimethaphan / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D005292:Ferricyanides; D010643:Phenoxybenzamine; D006830:Hydralazine; D008750:Methyldopa; D014294:Trimethaphan; D005665:Furosemide; D010425:Pentolinium Tartrate; D004976:Ethacrynic Acid; D003981:Diazoxide; D010646:Phentolamine